Why Will not we see more head-to-head trials of competitor medication? The answer is really very simple, Actually: threat management. For medicine which might be on patent, such as GLP-1s, conducting a trial with no invest in-in in the pharmaceutical company is simply too highly-priced — we will not operate a demo Unless of course somebody delive